HeartBeam, Inc.
HeartBeam, Inc. (BEAT) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
beat · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for HeartBeam, Inc. (BEAT) measures how much investors pay for each dollar of the company's trailing earnings. BEAT's current PE ratio of N/A is calculated by dividing its stock price of $0.81 by its TTM earnings per share of -$0.50.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 4 fiscal years · Front-end computedMinQ1 · 25%6.6x
MedianQ3 · 75%17.1x
Max
At N/A, BEAT's current P/E is lower than in 0% of its annual fiscal year readings over the past 4 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Healthcare Information Services · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
HeartBeam, Inc.You BEAT | $28M | N/A | — | -$0.50 |
 CervoMed Inc. CRVO | $27M | N/A | — | -$2.98 |
 Equillium, Inc. EQ | $98M | N/A | — | -$0.24 |
 Werewolf Therapeutics, Inc. HOWL | $19M | N/A | — | -$1.32 |
 MiNK Therapeutics, Inc. INKT | $56M | N/A | — | -$2.93 |
 IO Biotech, Inc. IOBT | $1M | N/A | — | -$1.45 |
 Spectral AI, Inc. MDAI | $59M | N/A | — | -$0.29 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.62 | — | |
2024-12-31 FY2024 | — | $-0.73 | — | |
2023-12-31 FY2023 | — | $-0.72 | — | |
2022-12-31 FY2022 | — | $-1.59 | — | |
2021-12-31 FY2021 | — | $-0.57 | — | |
2020-12-31 FY2020 | — | $-0.13 | — | |
2019-12-31 FY2019 | — | $-0.07 | — | |
2018-12-31 FY2018 | 3.92x | $1.20 | — | |
2017-12-31 FY2017 | — | $-0.53 | — | |
2016-12-31 FY2016 | 2.45x | $1.91 | -85.7% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for HeartBeam, Inc. (BEAT) measures how much investors pay for each dollar of the company's trailing earnings. BEAT's current PE ratio of N/A is calculated by dividing its stock price of $0.81 by its TTM earnings per share of -$0.50.
Frequently asked questions
BEAT pe ratio · 6 questionsBEAT's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.81 and TTM EPS of -$0.50. Data sourced from Financial Modeling Prep via BEAT's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · HeartBeam, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08